Skip to main content
Clinical Trials/NCT04663724
NCT04663724RecruitingNot Applicable

Computer-Based Treatment for Social Anxiety Disorder, A Randomized Controlled Trial

New York State Psychiatric Institute1 site in 1 country80 target enrollmentStarted: February 15, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
80
Locations
1
Primary Endpoint
Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)

Study Overview

Brief Summary

The present study is a controlled trial that seeks to examine the feasibility, acceptability, mechanism, and efficacy of a recently developed computer-based therapy in individuals with social anxiety disorder (SAD)

Detailed Description

This randomized clinical trial examines the feasibility, acceptability, mechanism, and relative efficacy of two forms of a recently developed 4-week/8-session computer-based therapy in individuals with social anxiety disorder (SAD). The purpose of this study is to assess whether a brief computer-based research treatment, provided in 30 minutes sessions, helps improve social anxiety symptoms, and by what mechanism. The study will also assess the effect of research treatments on brain activity using magnetic resonance imaging (MRI).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Males and females between the ages of 18 to 60
  • Current primary diagnosis of SAD
  • Score of at least 50 on the Liebowitz Social Anxiety Scale (self-rated version)
  • Fluent in English
  • Willing and able to give informed written consent
  • Ability to participate responsibly in the protocol
  • Normal or corrected-to-normal vision

Exclusion Criteria

  • Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
  • Current severe depression
  • Suicidal ideation or behavior
  • Current diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
  • Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
  • Current unstable or untreated medical illness
  • Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders)
  • Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), buspirone, or zolpidem for sleep for at least 3 months
  • Any concurrent cognitive behavioral therapy or other psychotherapy that was initiated in the past 3 months
  • Contraindication to MRI scanning

Arms & Interventions

Experimental Computer-Based Treatment

Experimental

A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.

Intervention: Computer-Based Treatment (Behavioral)

Comparator Computer-Based Treatment

Active Comparator

A 4-week (8-sessions) course of computer-based treatment. Participants will receive treatment twice a week for four weeks.

Intervention: Computer-Based Treatment (Behavioral)

Outcomes

Primary Outcomes

Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)

Time Frame: From baseline up to Month 4

Clinician-rated scale scoring anxiety (0, none to 3, severe) and avoidance (0,none to 3, severe) in 24 social situations for a total score of 0 to 144. Higher scores indicate greater social anxiety.

Change in Total Score of Quality of Life Enjoyment & Satisfaction Questionnaire

Time Frame: From baseline up to Month 4

Quality of Life Enjoyment \& Satisfaction Questionnaire (Q-LES-Q): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.

Secondary Outcomes

  • Change in Total Score of Social Phobia Inventory (SPIN)(Baseline to Month 4)
  • Clinical Global Impression-Change Scale(Baseline to Month 4)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Franklin Schneier

Director, Anxiety Disorders Clinic

New York State Psychiatric Institute

Study Sites (1)

Loading locations...

Similar Trials

Computer - Based Treatment for Social... | Clinical Trial